What is Renasant Bio worth?
$78.0Mlast known valuation
Renasant Bio last raised $30.0M in its Early Stage VC (Jun 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Renasant Bio
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2025 | Early Stage VC | $30.0M | ▮ | ▮ |
| Jul 2024 | Early Stage VC | $25.5M | ▮ | ▮ |
How Renasant Bio's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Renasant Bio, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Renasant Bio worth?
- Renasant Bio's last known valuation is $78.0M.
- How much has Renasant Bio raised?
- Renasant Bio has raised $55.5M in total funding across 2 recorded rounds.
- When did Renasant Bio last raise?
- Renasant Bio last raised in Jun 2025 (Early Stage VC), raising $30.0M.